HEADER TRANSFERASE 07-OCT-21 7PWQ TITLE PARP15 CATALYTIC DOMAIN IN COMPLEX WITH OUL240 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN MONO-ADP-RIBOSYLTRANSFERASE PARP15; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ADP-RIBOSYLTRANSFERASE DIPHTHERIA TOXIN-LIKE 7,ARTD7,B- COMPND 5 AGGRESSIVE LYMPHOMA PROTEIN 3,POLY [ADP-RIBOSE] POLYMERASE 15,PARP- COMPND 6 15; COMPND 7 EC: 2.4.2.-; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PARP15, BAL3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS ADP-RIBOSYLTRANSFERASE, INHIBITOR, COMPLEX, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR M.M.MAKSIMAINEN,L.LEHTIO REVDAT 2 31-JAN-24 7PWQ 1 REMARK REVDAT 1 11-MAY-22 7PWQ 0 JRNL AUTH M.G.NIZI,M.M.MAKSIMAINEN,S.MURTHY,S.MASSARI,J.ALAVIUHKOLA, JRNL AUTH 2 B.E.LIPPOK,S.T.SOWA,A.GALERA-PRAT,R.PRUNSKAITE-HYYRYLAINEN, JRNL AUTH 3 B.LUSCHER,P.KORN,L.LEHTIO,O.TABARRINI JRNL TITL POTENT 2,3-DIHYDROPHTHALAZINE-1,4-DIONE DERIVATIVES AS DUAL JRNL TITL 2 INHIBITORS FOR MONO-ADP-RIBOSYLTRANSFERASES PARP10 AND JRNL TITL 3 PARP15. JRNL REF EUR.J.MED.CHEM. V. 237 14362 2022 JRNL REFN ISSN 0223-5234 JRNL PMID 35500474 JRNL DOI 10.1016/J.EJMECH.2022.114362 REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0267 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.03 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 3 NUMBER OF REFLECTIONS : 54355 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.187 REMARK 3 R VALUE (WORKING SET) : 0.185 REMARK 3 FREE R VALUE : 0.218 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2861 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.70 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.74 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3974 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.76 REMARK 3 BIN R VALUE (WORKING SET) : 0.2660 REMARK 3 BIN FREE R VALUE SET COUNT : 209 REMARK 3 BIN FREE R VALUE : 0.2670 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3190 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 28 REMARK 3 SOLVENT ATOMS : 336 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 19.28 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.48000 REMARK 3 B22 (A**2) : 0.21000 REMARK 3 B33 (A**2) : 0.26000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.097 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.097 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.069 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.101 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.955 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.935 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3373 ; 0.008 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 3085 ; 0.001 ; 0.017 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4585 ; 1.497 ; 1.662 REMARK 3 BOND ANGLES OTHERS (DEGREES): 7112 ; 1.345 ; 1.588 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 408 ; 6.745 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 196 ;31.740 ;22.449 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 559 ;12.935 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 21 ;17.807 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 428 ; 0.072 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3888 ; 0.008 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 852 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 7PWQ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 07-OCT-21. REMARK 100 THE DEPOSITION ID IS D_1292118558. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-NOV-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : MASSIF-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.96546 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 57216 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 200 DATA REDUNDANCY : 3.900 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 5.5500 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.74 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 7OTH REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.25 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.52 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M AMMONIUM CHLORIDE PH 7.5, 20% REMARK 280 PEG 3350, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 22.86000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 80.82500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 34.74000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 80.82500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 22.86000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 34.74000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2450 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19270 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -22.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 458 REMARK 465 HIS A 459 REMARK 465 HIS A 460 REMARK 465 HIS A 461 REMARK 465 HIS A 462 REMARK 465 HIS A 463 REMARK 465 HIS A 464 REMARK 465 SER A 465 REMARK 465 SER A 466 REMARK 465 GLY A 467 REMARK 465 VAL A 468 REMARK 465 ASP A 469 REMARK 465 LEU A 470 REMARK 465 GLY A 471 REMARK 465 THR A 472 REMARK 465 GLU A 473 REMARK 465 ASN A 474 REMARK 465 LEU A 475 REMARK 465 TYR A 476 REMARK 465 PHE A 477 REMARK 465 GLN A 478 REMARK 465 SER A 479 REMARK 465 MET A 480 REMARK 465 ALA A 579 REMARK 465 GLY A 580 REMARK 465 LYS A 581 REMARK 465 MET B 458 REMARK 465 HIS B 459 REMARK 465 HIS B 460 REMARK 465 HIS B 461 REMARK 465 HIS B 462 REMARK 465 HIS B 463 REMARK 465 HIS B 464 REMARK 465 SER B 465 REMARK 465 SER B 466 REMARK 465 GLY B 467 REMARK 465 VAL B 468 REMARK 465 ASP B 469 REMARK 465 LEU B 470 REMARK 465 GLY B 471 REMARK 465 THR B 472 REMARK 465 GLU B 473 REMARK 465 ASN B 474 REMARK 465 LEU B 475 REMARK 465 TYR B 476 REMARK 465 PHE B 477 REMARK 465 GLN B 478 REMARK 465 SER B 479 REMARK 465 MET B 480 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 552 49.65 -107.88 REMARK 500 TYR A 604 -65.19 -103.08 REMARK 500 PRO A 640 2.37 -67.28 REMARK 500 HIS B 491 -20.92 77.37 REMARK 500 ASP B 549 -91.03 -57.98 REMARK 500 ASN B 653 118.57 -161.94 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 7PW3 RELATED DB: PDB REMARK 900 RELATED ID: 7PWA RELATED DB: PDB REMARK 900 RELATED ID: 7PWC RELATED DB: PDB REMARK 900 RELATED ID: 7PWK RELATED DB: PDB REMARK 900 RELATED ID: 7PWL RELATED DB: PDB REMARK 900 RELATED ID: 7PWM RELATED DB: PDB REMARK 900 RELATED ID: 7PWP RELATED DB: PDB DBREF 7PWQ A 481 678 UNP Q460N3 PAR15_HUMAN 481 678 DBREF 7PWQ B 481 678 UNP Q460N3 PAR15_HUMAN 481 678 SEQADV 7PWQ MET A 458 UNP Q460N3 INITIATING METHIONINE SEQADV 7PWQ HIS A 459 UNP Q460N3 EXPRESSION TAG SEQADV 7PWQ HIS A 460 UNP Q460N3 EXPRESSION TAG SEQADV 7PWQ HIS A 461 UNP Q460N3 EXPRESSION TAG SEQADV 7PWQ HIS A 462 UNP Q460N3 EXPRESSION TAG SEQADV 7PWQ HIS A 463 UNP Q460N3 EXPRESSION TAG SEQADV 7PWQ HIS A 464 UNP Q460N3 EXPRESSION TAG SEQADV 7PWQ SER A 465 UNP Q460N3 EXPRESSION TAG SEQADV 7PWQ SER A 466 UNP Q460N3 EXPRESSION TAG SEQADV 7PWQ GLY A 467 UNP Q460N3 EXPRESSION TAG SEQADV 7PWQ VAL A 468 UNP Q460N3 EXPRESSION TAG SEQADV 7PWQ ASP A 469 UNP Q460N3 EXPRESSION TAG SEQADV 7PWQ LEU A 470 UNP Q460N3 EXPRESSION TAG SEQADV 7PWQ GLY A 471 UNP Q460N3 EXPRESSION TAG SEQADV 7PWQ THR A 472 UNP Q460N3 EXPRESSION TAG SEQADV 7PWQ GLU A 473 UNP Q460N3 EXPRESSION TAG SEQADV 7PWQ ASN A 474 UNP Q460N3 EXPRESSION TAG SEQADV 7PWQ LEU A 475 UNP Q460N3 EXPRESSION TAG SEQADV 7PWQ TYR A 476 UNP Q460N3 EXPRESSION TAG SEQADV 7PWQ PHE A 477 UNP Q460N3 EXPRESSION TAG SEQADV 7PWQ GLN A 478 UNP Q460N3 EXPRESSION TAG SEQADV 7PWQ SER A 479 UNP Q460N3 EXPRESSION TAG SEQADV 7PWQ MET A 480 UNP Q460N3 EXPRESSION TAG SEQADV 7PWQ MET B 458 UNP Q460N3 INITIATING METHIONINE SEQADV 7PWQ HIS B 459 UNP Q460N3 EXPRESSION TAG SEQADV 7PWQ HIS B 460 UNP Q460N3 EXPRESSION TAG SEQADV 7PWQ HIS B 461 UNP Q460N3 EXPRESSION TAG SEQADV 7PWQ HIS B 462 UNP Q460N3 EXPRESSION TAG SEQADV 7PWQ HIS B 463 UNP Q460N3 EXPRESSION TAG SEQADV 7PWQ HIS B 464 UNP Q460N3 EXPRESSION TAG SEQADV 7PWQ SER B 465 UNP Q460N3 EXPRESSION TAG SEQADV 7PWQ SER B 466 UNP Q460N3 EXPRESSION TAG SEQADV 7PWQ GLY B 467 UNP Q460N3 EXPRESSION TAG SEQADV 7PWQ VAL B 468 UNP Q460N3 EXPRESSION TAG SEQADV 7PWQ ASP B 469 UNP Q460N3 EXPRESSION TAG SEQADV 7PWQ LEU B 470 UNP Q460N3 EXPRESSION TAG SEQADV 7PWQ GLY B 471 UNP Q460N3 EXPRESSION TAG SEQADV 7PWQ THR B 472 UNP Q460N3 EXPRESSION TAG SEQADV 7PWQ GLU B 473 UNP Q460N3 EXPRESSION TAG SEQADV 7PWQ ASN B 474 UNP Q460N3 EXPRESSION TAG SEQADV 7PWQ LEU B 475 UNP Q460N3 EXPRESSION TAG SEQADV 7PWQ TYR B 476 UNP Q460N3 EXPRESSION TAG SEQADV 7PWQ PHE B 477 UNP Q460N3 EXPRESSION TAG SEQADV 7PWQ GLN B 478 UNP Q460N3 EXPRESSION TAG SEQADV 7PWQ SER B 479 UNP Q460N3 EXPRESSION TAG SEQADV 7PWQ MET B 480 UNP Q460N3 EXPRESSION TAG SEQRES 1 A 221 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU SEQRES 2 A 221 GLY THR GLU ASN LEU TYR PHE GLN SER MET ASN LEU PRO SEQRES 3 A 221 GLU HIS TRP THR ASP MET ASN HIS GLN LEU PHE CYS MET SEQRES 4 A 221 VAL GLN LEU GLU PRO GLY GLN SER GLU TYR ASN THR ILE SEQRES 5 A 221 LYS ASP LYS PHE THR ARG THR CYS SER SER TYR ALA ILE SEQRES 6 A 221 GLU LYS ILE GLU ARG ILE GLN ASN ALA PHE LEU TRP GLN SEQRES 7 A 221 SER TYR GLN VAL LYS LYS ARG GLN MET ASP ILE LYS ASN SEQRES 8 A 221 ASP HIS LYS ASN ASN GLU ARG LEU LEU PHE HIS GLY THR SEQRES 9 A 221 ASP ALA ASP SER VAL PRO TYR VAL ASN GLN HIS GLY PHE SEQRES 10 A 221 ASN ARG SER CYS ALA GLY LYS ASN ALA VAL SER TYR GLY SEQRES 11 A 221 LYS GLY THR TYR PHE ALA VAL ASP ALA SER TYR SER ALA SEQRES 12 A 221 LYS ASP THR TYR SER LYS PRO ASP SER ASN GLY ARG LYS SEQRES 13 A 221 HIS MET TYR VAL VAL ARG VAL LEU THR GLY VAL PHE THR SEQRES 14 A 221 LYS GLY ARG ALA GLY LEU VAL THR PRO PRO PRO LYS ASN SEQRES 15 A 221 PRO HIS ASN PRO THR ASP LEU PHE ASP SER VAL THR ASN SEQRES 16 A 221 ASN THR ARG SER PRO LYS LEU PHE VAL VAL PHE PHE ASP SEQRES 17 A 221 ASN GLN ALA TYR PRO GLU TYR LEU ILE THR PHE THR ALA SEQRES 1 B 221 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU SEQRES 2 B 221 GLY THR GLU ASN LEU TYR PHE GLN SER MET ASN LEU PRO SEQRES 3 B 221 GLU HIS TRP THR ASP MET ASN HIS GLN LEU PHE CYS MET SEQRES 4 B 221 VAL GLN LEU GLU PRO GLY GLN SER GLU TYR ASN THR ILE SEQRES 5 B 221 LYS ASP LYS PHE THR ARG THR CYS SER SER TYR ALA ILE SEQRES 6 B 221 GLU LYS ILE GLU ARG ILE GLN ASN ALA PHE LEU TRP GLN SEQRES 7 B 221 SER TYR GLN VAL LYS LYS ARG GLN MET ASP ILE LYS ASN SEQRES 8 B 221 ASP HIS LYS ASN ASN GLU ARG LEU LEU PHE HIS GLY THR SEQRES 9 B 221 ASP ALA ASP SER VAL PRO TYR VAL ASN GLN HIS GLY PHE SEQRES 10 B 221 ASN ARG SER CYS ALA GLY LYS ASN ALA VAL SER TYR GLY SEQRES 11 B 221 LYS GLY THR TYR PHE ALA VAL ASP ALA SER TYR SER ALA SEQRES 12 B 221 LYS ASP THR TYR SER LYS PRO ASP SER ASN GLY ARG LYS SEQRES 13 B 221 HIS MET TYR VAL VAL ARG VAL LEU THR GLY VAL PHE THR SEQRES 14 B 221 LYS GLY ARG ALA GLY LEU VAL THR PRO PRO PRO LYS ASN SEQRES 15 B 221 PRO HIS ASN PRO THR ASP LEU PHE ASP SER VAL THR ASN SEQRES 16 B 221 ASN THR ARG SER PRO LYS LEU PHE VAL VAL PHE PHE ASP SEQRES 17 B 221 ASN GLN ALA TYR PRO GLU TYR LEU ILE THR PHE THR ALA HET 8A8 A 701 20 HET MPD A 702 8 HETNAM 8A8 6-(CYCLOHEXYLMETHOXY)PHTHALAZINE-1,4-DIONE HETNAM MPD (4S)-2-METHYL-2,4-PENTANEDIOL FORMUL 3 8A8 C15 H16 N2 O3 FORMUL 4 MPD C6 H14 O2 FORMUL 5 HOH *336(H2 O) HELIX 1 AA1 GLN A 503 SER A 518 1 16 HELIX 2 AA2 ALA A 531 ASP A 549 1 19 HELIX 3 AA3 ASP A 562 ASP A 564 5 3 HELIX 4 AA4 SER A 565 GLY A 573 1 9 HELIX 5 AA5 ASP A 595 ALA A 600 1 6 HELIX 6 AA6 GLN B 503 SER B 518 1 16 HELIX 7 AA7 ALA B 531 ASN B 548 1 18 HELIX 8 AA8 ASP B 562 ASP B 564 5 3 HELIX 9 AA9 SER B 565 GLY B 573 1 9 HELIX 10 AB1 ASN B 575 ALA B 579 5 5 HELIX 11 AB2 ASP B 595 ALA B 600 1 6 SHEET 1 AA1 5 PHE A 494 GLN A 498 0 SHEET 2 AA1 5 ALA A 521 ASN A 530 -1 O ARG A 527 N VAL A 497 SHEET 3 AA1 5 ALA A 668 THR A 677 -1 O THR A 675 N LYS A 524 SHEET 4 AA1 5 LYS A 613 LEU A 621 -1 N MET A 615 O ILE A 674 SHEET 5 AA1 5 GLU A 554 THR A 561 -1 N LEU A 557 O VAL A 618 SHEET 1 AA2 4 THR A 590 ALA A 593 0 SHEET 2 AA2 4 LEU A 659 VAL A 662 -1 O VAL A 662 N THR A 590 SHEET 3 AA2 4 SER A 649 THR A 651 -1 N VAL A 650 O VAL A 661 SHEET 4 AA2 4 PHE A 625 LYS A 627 1 N THR A 626 O THR A 651 SHEET 1 AA3 5 PHE B 494 GLN B 498 0 SHEET 2 AA3 5 ALA B 521 ASN B 530 -1 O ARG B 527 N VAL B 497 SHEET 3 AA3 5 ALA B 668 THR B 677 -1 O THR B 677 N ALA B 521 SHEET 4 AA3 5 LYS B 613 LEU B 621 -1 N MET B 615 O ILE B 674 SHEET 5 AA3 5 GLU B 554 THR B 561 -1 N LEU B 557 O VAL B 618 SHEET 1 AA4 4 THR B 590 ALA B 593 0 SHEET 2 AA4 4 LEU B 659 VAL B 662 -1 O PHE B 660 N PHE B 592 SHEET 3 AA4 4 SER B 649 THR B 651 -1 N VAL B 650 O VAL B 661 SHEET 4 AA4 4 PHE B 625 LYS B 627 1 N THR B 626 O THR B 651 CRYST1 45.720 69.480 161.650 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021872 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014393 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006186 0.00000